| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/21/2002 | WO2002022880A1 Compositions and methods for the identification of viral inhibitors of host cell protein synthesis shut-off |
| 03/21/2002 | WO2002022876A1 Method of identifying putative antibiotic resistance genes |
| 03/21/2002 | WO2002022875A2 Polymorphisms associated with cardiac arrythmia |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022848A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | WO2002022843A2 Nucleotide sequences which code for the dep34 gene |
| 03/21/2002 | WO2002022837A2 Identification and characterization of a dwarf and late flowering 2 phenotype (dlf2) in arabidopsis |
| 03/21/2002 | WO2002022832A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 03/21/2002 | WO2002022825A2 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
| 03/21/2002 | WO2002022824A2 Ashbya gossypii genes coding for proteins involved in membrane transport |
| 03/21/2002 | WO2002022823A2 Proteins involved in the stress response and genes from ashbya gossypii coding for the same |
| 03/21/2002 | WO2002022822A2 Plant derived bag homologues |
| 03/21/2002 | WO2002022821A2 Antimicrobial peptides and methods of use |
| 03/21/2002 | WO2002022820A1 Inhibition of stenosis or restenosis by p-selectin antagonists |
| 03/21/2002 | WO2002022819A2 Calcium binding proteins |
| 03/21/2002 | WO2002022818A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 03/21/2002 | WO2002022817A2 Nuclear receptor l66 and methods of use |
| 03/21/2002 | WO2002022816A1 A novel polypeptide- estrogen receptor related protein 14.19 and the polynucleotide encoding said polypeptide |
| 03/21/2002 | WO2002022815A1 Methods and materials relating to neuropilin-like polypeptides and polynucleotides |
| 03/21/2002 | WO2002022814A2 Nucleotide sequences which code for the atr43 gene |
| 03/21/2002 | WO2002022813A1 Method of screening hypoglycemic substance by using stat inhibitory factor-1 |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022808A2 Cripto mutant and uses thereof |
| 03/21/2002 | WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | WO2002022805A2 Modulation of il-2- and il-15-mediated t cell responses |
| 03/21/2002 | WO2002022803A2 Peptide epitopes recognized by antigen specific cd4+ t lymphocytes |
| 03/21/2002 | WO2002022802A1 Novel compounds |
| 03/21/2002 | WO2002022801A2 Mammalian receptor genes and uses |
| 03/21/2002 | WO2002022799A2 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
| 03/21/2002 | WO2002022798A2 Modulation of homologous recombination with single stranded dna binding proteins |
| 03/21/2002 | WO2002022784A2 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g |
| 03/21/2002 | WO2002022783A2 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 03/21/2002 | WO2002022782A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | WO2002022780A2 Methods and materials relating to neuropilin-like polypeptides and polynucleotides |
| 03/21/2002 | WO2002022777A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 03/21/2002 | WO2002022776A2 Human coagulation factor vii variants |
| 03/21/2002 | WO2002022687A2 Viral chemokine-tumur antigen fusion proteins |
| 03/21/2002 | WO2002022686A2 Defensin-antigen fusion proteins |
| 03/21/2002 | WO2002022685A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022683A1 Novel dendritic cell wall membrane and use thereof |
| 03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
| 03/21/2002 | WO2002022681A2 Neuronally expressed protein and use thereof |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2002022679A2 Variants of phleum pratense allergenic proteins |
| 03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | WO2002022677A2 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 03/21/2002 | WO2002022676A1 A longevity guarantee protein and its encoding sequence and use |
| 03/21/2002 | WO2002022675A2 Plant genes, the expression of which are altered by pathogen infection |
| 03/21/2002 | WO2002022674A2 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Parietaria judaica |
| 03/21/2002 | WO2002022673A2 Proteins participating in nucleotide metabolism and genes coding for the same from ashbya gossypii |
| 03/21/2002 | WO2002022672A1 Nucleotide sequences coding for the ccsb gene |
| 03/21/2002 | WO2002022671A1 Nucleotide sequences coding for the pstc2 gene |
| 03/21/2002 | WO2002022670A1 Nucleotide sequences coding for the ftsx gene |
| 03/21/2002 | WO2002022669A1 Nucleotide sequences coding for the suga gene |
| 03/21/2002 | WO2002022668A1 Nucleotide sequences which code for the roda gene |
| 03/21/2002 | WO2002022667A2 Twin-arginine translocation in bacillus |
| 03/21/2002 | WO2002022665A1 Novel g protein-coupled receptor proteins and dnas tehreof |
| 03/21/2002 | WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | WO2002022663A2 Stress resistant retroviruses |
| 03/21/2002 | WO2002022662A2 Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor |
| 03/21/2002 | WO2002022660A2 Novel nucleic acids and polypeptides |
| 03/21/2002 | WO2002022659A2 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II |
| 03/21/2002 | WO2002022658A2 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 03/21/2002 | WO2002022656A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 03/21/2002 | WO2002022654A1 17 human secreted proteins |
| 03/21/2002 | WO2002022653A1 Method of constructing three-dimensional structure of transmembrane protein |
| 03/21/2002 | WO2002022652A2 Haplotypes of the slc18a2 gene |
| 03/21/2002 | WO2002022651A2 Haplotypes of the ccr8 gene |
| 03/21/2002 | WO2002022650A2 Haplotypes of the per1 gene |
| 03/21/2002 | WO2002022648A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | WO2002022644A1 Haplotypes of the gpr7 gene |
| 03/21/2002 | WO2002022642A1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 03/21/2002 | WO2002022638A1 22 human secreted proteins |
| 03/21/2002 | WO2002022633A2 Nucleotide sequences which code for the atr61 gene |
| 03/21/2002 | WO2002022571A2 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 03/21/2002 | WO2002022159A1 Thionin as an antineoplastic and immunostimulant |
| 03/21/2002 | WO2002022155A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 03/21/2002 | WO2002022153A2 Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2002022077A2 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2002002142B1 Papillomavirus vaccine |
| 03/21/2002 | WO2002000927A8 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 03/21/2002 | WO2002000706A3 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them |
| 03/21/2002 | WO2002000024A8 New strategy for leukemia therapy |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001096867A3 Method for identifying insulin mimics or antagonists |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001096380A8 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 03/21/2002 | WO2001094569A3 Corynebacterium glutamicum nucleotide sequences coding for the glbo gene |
| 03/21/2002 | WO2001088115B1 Transgenic caenorhabditis elegans model exhibiting a neuronal dysfunction |
| 03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001085780A8 Nucleic acid binding polypeptides |
| 03/21/2002 | WO2001083809A3 Cell membrane nucleic acid transport channel complex |
| 03/21/2002 | WO2001083703A3 Checkpoint-activating oligonucleotides |
| 03/21/2002 | WO2001082962A3 Immunizing against hiv infection |
| 03/21/2002 | WO2001081546A3 CeSERT GENES, PROTEINS, AND MODULATORY COMPOUNDS |